CHAPTER 683
H.P. 1535 - L.D. 2038
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §1317-A, as amended by PL 1999, c. 276, §7, is repealed.
Sec. 2. 22 MRSA §1317-C, sub-§1, as enacted by PL 1991, c. 810, §23, is amended to read:
1. Screening. Beginning January 1, 1994, all All health care providers must shall advise parents of the availability and advisability of screening their children for lead poisoning. By January 1, 1994, any A health care program that receives funds from the State and has a child health component must shall provide screening of children for lead poisoning in accordance with rules adopted by the department.
Sec. 3. 22 MRSA §1317-D is enacted to read:
§1317-D. Lead poisoning risk assessment and blood lead level testing program
The commissioner shall establish a lead poisoning risk assessment and blood lead level testing program, referred to in this section as the "program," for assessment of lead poisoning risks to children and the testing of blood lead levels in children in accordance with this section and within the limits of available funding.
1. Lead poisoning risk assessment tool. The program must include a simplified lead poisoning risk assessment tool, developed by the department, based on questions from the United States Department of Health and Human Services, Centers for Disease Control and Prevention.
2. Information. The program must include the distribution of information on lead poisoning risk assessment to providers for children.
3. Testing of children covered by MaineCare program. As required by Section 1905(r)(5) of the Social Security Act and the federal Omnibus Budget Reconciliation Act of 1989, the program must require the testing of blood lead levels of all children covered by the MaineCare program at one year of age and 2 years of age. The drawing of blood for the testing may be done in the health care provider's office or may be referred to another laboratory.
4. Testing of children not covered by MaineCare program. The program must require the testing of blood lead levels of all children not covered by the MaineCare program at one year of age and 2 years of age unless, in the professional judgment of the provider of primary health care, in conjunction with the use of the lead poisoning risk assessment tool, the child's level of risk does not warrant a blood lead level test. The drawing of blood for the testing may be done in the health care provider's office or may be referred to another laboratory.
5. Inspections. The program must conduct comprehensive environmental lead inspections and technical assistance and give advice regarding the appropriate reduction of environmental lead hazards to families with children who have elevated levels of lead in their blood.
6. Funding. As resources permit and in accordance with rules adopted by the department, pursuant to section 1323, the program must include payment by the department for blood lead level testing and related services and diagnostic evaluations when a child's parent is unable to pay and does not have health coverage for testing and services.
7. Exception. This section does not apply to a child whose parent or guardian objects to that child's participation in the program on the grounds that the assessment or testing is contrary to the parent's or guardian's sincerely held religious or philosophical beliefs.
Sec. 4. 22 MRSA §1319-A, first ¶, as enacted by PL 1991, c. 810, §26, is amended to read:
Beginning January 1, 1993, any A blood sample taken from a child by a health care provider or laboratory to test for blood lead level must be sent to the State Health and Environmental Testing Laboratory for analysis. By January 1, 1993, the The department shall adopt rules regarding lead-related testing conducted by the State Health and Environmental Testing Laboratory. Whenever possible, the laboratory shall bill 3rd-party payors for services provided under this chapter and shall deposit all fees received into the State Health and Environmental Testing Laboratory dedicated account. The laboratory shall use the funds to:
Sec. 5. 22 MRSA §1323, sub-§§9 and 10, as enacted by PL 1991, c. 810, §31, are amended to read:
9. Fees. Establishing fees for services performed under this chapter; and
10. Advisory boards. Establishing boards or commissions to advise the department regarding lead poisoning.; and
Sec. 6. 22 MRSA §1323, sub-§11 is enacted to read:
11. Risk assessment and testing. Developing the lead poisoning risk assessment tool and the requirements for its administration and testing for blood lead levels, pursuant to section 1317-D.
Sec. 7. Lead screening task force. The Department of Human Services and any boards or advisory commissions established to advise the department pursuant to the Maine Revised Statutes, Title 22, section 1323, subsection 10 shall convene a task force of representatives of pertinent health care organizations to determine the standard lead poisoning risk assessment tool for use statewide pursuant to Title 22, section 1317-D, subsection 1, to help disseminate the assessment tool and information on lead poisoning and to assist in developing additional recommendations that will increase lead screening in the State pursuant to Title 22, section 1317-D, subsection 2. By January 1, 2004, the department shall report on the initial work of the task force to the joint standing committee of the Legislature having jurisdiction over health and human services matters.
Sec. 8. Report; review. By March 1, 2005, the Department of Human Services shall report to the joint standing committee of the Legislature having jurisdiction over health and human services matters regarding the extent and result of lead poisoning risk assessment and blood lead level testing pursuant to the Maine Revised Statutes, Title 22, section 1317-D.
Sec. 9. Appropriations and allocations. The following appropriations and allocations are made.
HUMAN SERVICES, DEPARTMENT OF
Medical Care - Payments to Providers 0147
Initiative: Provides funds to cover the costs incurred by a health care provider for performing a drawing of blood for the blood lead level test for children covered by the MaineCare program.
General Fund 2001-02 2002-03
All Other $0 $50,000
____________ ____________
Total $0 $50,000
Federal Expenditures Fund 2001-02 2002-03
All Other $0 $98,412
____________ ____________
Total $0 $98,412
HUMAN SERVICES, DEPARTMENT OF
DEPARTMENT TOTAL 2001-02 2002-03
GENERAL FUND $0 $50,000
FEDERAL EXPENDITURES
FUND 0 98,412
____________ ____________
DEPARTMENT TOTALS -
ALL FUNDS $0 $148,412
Sec. 10. Effective date. This Act takes effect January 1, 2003.
Effective January 1, 2003.
Revisor of Statutes Homepage | Subject Index | Search | 120th Laws of Maine | Maine Legislature |